U.S. Stem Cell, Inc. engages in the research, development, and commercialization of stem cell and regenerative treatments in the United States and internationally. The company develops MyoCell, an autologous muscle stem cell therapy which is preparing for phase II/III clinical trials for the treatme... U.S. Stem Cell, Inc. engages in the research, development, and commercialization of stem cell and regenerative treatments in the United States and internationally. The company develops MyoCell, an autologous muscle stem cell therapy which is preparing for phase II/III clinical trials for the treatment of heart damage in heart failure patients; MyoCell SDF-1, an autologous cell therapy which completed the IND application for the treatment of chronic damage in the heart and enhancement of blood vessel formation; and AdipoCell, a clinical protocol and kit which is preparing for clinical trials for the treatment of chronic ischemic cardiomyopathy. It also offers regenerative medicine solutions to veterinarians; and training programs for physicians to perform bone marrow derived stem cell protocols. The company was formerly known as Bioheart, Inc. and changed its name to U.S. Stem Cell, Inc. in November 2015. U.S. Stem Cell, Inc. was incorporated in 1999 and is headquartered in Sunrise, Florida. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0.0001 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 99456 | 9.925E-5 | CS |
| 12 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 125846 | 5.527E-5 | CS |
| 26 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 303587 | 3.797E-5 | CS |
| 52 | 0 | 0 | 0.0001 | 0.0002 | 1.0E-6 | 229050 | 3.988E-5 | CS |
| 156 | -0.00227 | -95.7805907173 | 0.00237 | 0.0031 | 1.0E-6 | 258280 | 0.00021418 | CS |
| 260 | -0.0144 | -99.3103448276 | 0.0145 | 0.0165 | 1.0E-6 | 603950 | 0.00684251 | CS |
TheWhigs
1年前
Dingster
2年前
TheWhigs
2年前
Dingster
2年前
TheWhigs
2年前
TheWhigs
2年前
Dingster
2年前
Coo breeze
2年前
TheWhigs
2年前
TheWhigs
2年前
TheWhigs
2年前
TheWhigs
2年前
TheWhigs
3年前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。